Mirati Therapeutics Inc (was acquisied by Bristol Myers Squibb (NYSE: BMY) on 23/01/2024) (MRTX) Provides Business Update
Mirati Therapeutics Inc (was acquisied by Bristol Myers Squibb (NYSE: BMY) on 23/01/2024) (MRTX) issued a business update covering recent developments.
🔍 Detailed Event Analysis:
AI Summary: Exhibit991-mirati2022equit.htm. form_8k_exhibit is a document created using Wdesk. The document is part of the 2022 Equity Incentive Plan. The plan was adopted by the Board of Directors on April 4, 2022.
Key Elements Identified:
Organizations: the Board of Directors
💼 Business Developments:
No business developments data available.
Structured Data:
Company Name: Mirati Therapeutics Inc (was acquisied by Bristol Myers Squibb (NYSE: BMY) on 23/01/2024)
📋 MIRATI THERAPEUTICS, INC. (MRTX) - Other Event
Filing Date: 2022-05-12
Accepted: 2022-05-12 17:07:12
Event Type: Other Event
Event Details:
🔍 Detailed Event Analysis:
AI Summary: Exhibit991-mirati2022equit.htm. form_8k_exhibit is a document created using Wdesk. The document is part of the 2022 Equity Incentive Plan. The plan was adopted by the Board of Directors on April 4, 2022.
Key Elements Identified:
💼 Business Developments:
No business developments data available.
Structured Data: